phase iia exploratory trial of t3d-959 in mild-moderate alzheimer’s disease
Published 1 year ago • 61 plays • Length 6:34Download video MP4
Download video MP3
Similar videos
-
9:17
phase ii trial of xpro1595 for the treatment of alzheimer’s disease
-
1:38
ct1812: exciting preliminary results
-
1:57
phase iii ahead 3-45 trial of lecanemab for preclinical alzheimer’s disease
-
1:27
uab involved in clinical trials for new fda-approved alzheimer's drug
-
7:14
phase iii admet2 trial of methylphenidate for apathy in alzheimer's disease
-
28:20
first phase 3 clinical trials targeting the tauopathy of alzheimer’s disease - claude wischik
-
2:39
drug to fight alzheimer's limited to those in clinical trials
-
0:51
volunteering for clinical trials when alzheimer's runs in your family - kay's story
-
0:57
an insider’s account of the alzheimer’s solanezumab drug trial #dementia #alzheimers #clinicaltrials
-
1:54
what’s next for clinical trials in alzheimer’s disease?
-
2:05
phase ii clinical trial of sage-718 for the treatment of mci and early ad
-
3:48
the power of composite tests to track alzheimer’s disease progression
-
4:14
dementia/alzheimer's clinical trials
-
2:14
clinical trial hopes to stop or slow alzheimer's disease in patients
-
1:00
alzheimer's clinical trial drug yields negative result
-
4:22
improving clinical trials for alzheimer’s disease therapies
-
1:52
the future of sage-718 in alzheimer’s disease treatment
-
1:00
what is alzheimer's disease? the importance of clinical trials
-
2:02
the role of phosphorylated tau in clinical trials